Maxcyte (MXCT) Cash from Operations (2020 - 2026)

Maxcyte (MXCT) has 7 years of Cash from Operations data on file, last reported at 8169000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations rose 43.31% year-over-year to 8169000.0 in Q1 2026; TTM through Mar 2026 was 28168000.0, a 10.46% increase from a year earlier, with the FY2025 full-year figure at 34410000.0, down 24.63% from the prior year.
• Cash from Operations for Q1 2026 stood at 8169000.0, down from 2689000.0 in the prior quarter.
• Over the last five years, Cash from Operations for MXCT reached as high as 981000.0 in Q4 2023 and fell as low as 14411000.0 in Q1 2025.
• Historically, Cash from Operations has averaged 6274000.0 across 5 years, with a median of 6086400.0 in 2022.
• Across the five-year window, Cash from Operations surged 120.94% in 2022 and plunged 1200.04% in 2023, its largest moves.
• Year by year, Cash from Operations stood at 6086400.0 in 2022, then soared by 116.12% to 981000.0 in 2023, then slumped by 897.25% to 7821000.0 in 2024, then jumped by 65.62% to 2689000.0 in 2025, then slumped by 203.79% to 8169000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 8169000.0 in Q1 2026, 2689000.0 in Q4 2025, and 7458000.0 in Q3 2025.